References
Centers for Disease Control. Tuberculosis — United States, 1985. MMWR Morb Mortal Wkly Rep 1986; 35: 699–703
Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in Western Europe. Bull World Health Organ 1993; 71: 297–306
Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ 1994; 72: 495–509
Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745–9
Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055–64
Hopewell PC. Tuberculosis and human immunodeficiency virus infection. Semin Respir Infect 1989; 4: 111–22
Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220–6
Barnum HN. Cost savings from alternative treatments for tuberculosis. Soc Sci Med 1986; 23: 847–50
The World Bank. World Development Report 1993: investing in Health. Oxford: Oxford University Press, 1993
Arno PS, Murray CJL, Bonuck KA, et al. The economic impact of tuberculosis in hospitals in New York City: a preliminary analysis. J Law Med Ethics 1993; 21: 317–23
Shulkin DJ, Brennan PJ. The cost of caring for patients with tuberculosis: planning for a disease on the rise. Am J Infect Control 1995; 23: 1–4
Brown RE, Miller B, Taylor WR, et al. Health-care expenditures for tuberculosis in the United States. Arch Intern Med 1995; 155: 1595–600
Frieden TR, Fujiwara PI, Washko RM, et al. Tuberculosis in New York City: turning the tide. N Engl J Med 1995; 333: 229–33
Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993; 270: 65–8
Tuberculosis Programme, WHO. Stop tuberculosis at the source: WHO report on the Tuberculosis Epidemic, 1995. Geneva: WHO, 1995
Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can’t afford not to try it. N Engl J Med 1993; 328: 576–8
China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358–62
Chaulet P. The supply of antituberculosis drugs: price evolution. Tuber Lung Dis 1995; 76: 261–3
Saunderson PR. An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. Soc Sci Med 1995; 40: 1203–12
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sawert, H. The Re-Emergence of Tuberculosis and its Economic Implications. Pharmacoeconomics 9, 379–381 (1996). https://doi.org/10.2165/00019053-199609050-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-199609050-00001